Reuters4d
Pfizer to sell $3 billion stake in Sensodyne maker Haleon
Jan 15 (Reuters) - Pfizer (PFE.N), opens new tab will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon (HLN.L), opens new tab, lowering its stake in the British consumer healthcare ...
PRWeek2y
GSK fuses old and new in consumer health arm’s new name ‘Haleon’
Unrestricted access to all Essential and Insights content Access to the PRWeek Consultancy Tracker and the Top 150 Monthly Trading Tracker Hub In-depth reports including quarterly and annual ...
Morningstar3d
Pfizer Sells 700 Million Haleon Shares for $3.05 Billion
Pfizer has sold 700 million shares in British consumer-healthcare business Haleon for 2.50 billion pounds, equivalent to US$3.05 billion, it said in a statement. The U.S. drugmaker said Wednesday ...